Table 1.
Baseline characteristics of the people living with HIV who were included in this study.
| Baseline characteristics | Overall cohort | HCV seronegative | HCV seropositive | HCV seroconverted |
|---|---|---|---|---|
| (n = 4199) | (n = 3375) | (n = 447) | (n = 377) | |
| Age, mean (SD), years | 35.4 (10.5) | 35.4 (10.6) | 40.0 (10.4) | 30.1 (6.8) |
| Male sex, n (%) | 4013 (95.6) | 3244 (96.1) | 392 (87.7) | 377 (100) |
| Risk group for HIV infection | ||||
| Men who have sex with men, n (%) | 3403 (81.0) | 2829 (83.8) | 213 (47.7) | 361 (95.8) |
| Injecting drug users, n (%) | 160 (3.8) | 21 (0.6) | 134 (30.0) | 5 (1.3) |
| Anti-HCV positivity at enrolment, n (%) | 447 (10.6) | 0 (0) | 447 (100) | 0 (0) |
| HBsAg positivity at enrolment, n (%) | 536/4100 (13.1) | 420/3298 (12.7) | 66/433 (15.2) | 50/369 (13.5) |
Abbreviations: HBsAg, hepatitis B surface antigen; HCV, hepatitis C virus; IQR, interquartile range; SD, standard deviation.